47 results about "Absolute concentration" patented technology

The apparatus for detecting the presence of a particular gas within a mixture of gases comprises first and second emitter means for emitting measurement and reference electromagnetic radiation beams respectively, which beams are activated in alternation, a measurement cell, a filter cell, first and second detector means for detecting electromagnetic radiation beams, a beam splitter, and acquisition and processing means for synchronously acquiring and processing the four signals <math-cwu id="MATH-US-00001"> <number>1</number> $U_S^1,U_S^2,U_R^1,U_R^2$ <mathematica-file id="MATHEMATICA-00001" file="US20020050567A1-20020502-M00001.NB"/> <image id="EMI-M00001" wi="216.027" he="11.02815" file="US20020050567A1-20020502-M00001.TIF" imf="TIFF" ti="MF"/> </math-cwu> delivered by the first and second detector means in succession when the first and second emitter means are respectively activated so as to determine the absolute concentration of the gas to be detected on the basis of the ratio <math-cwu id="MATH-US-00002"> <number>2</number> $R=\left(U_S^{1}x{U}_R^2\right)/\left(U_S^{2}x{U}_R^1\right)$ <mathematica-file id="MATHEMATICA-00002" file="US20020050567A1-20020502-M00002.NB"/> <image id="EMI-M00002" wi="216.027" he="11.02815" file="US20020050567A1-20020502-M00002.TIF" imf="TIFF" ti="MF"/> </math-cwu> between the four signals, in which <math-cwu id="MATH-US-00003"> <number>3</number> $U_S^1\mathrm{and}{U}_S^2$ <mathematica-file id="MATHEMATICA-00003" file="US20020050567A1-20020502-M00003.NB"/> <image id="EMI-M00003" wi="216.027" he="11.02815" file="US20020050567A1-20020502-M00003.TIF" imf="TIFF" ti="MF"/> </math-cwu> respectively represent the signals delivered by the first and second detector means when the first emitter means is activated, and <math-cwu id="MATH-US-00004"> <number>4</number> $U_R^1\mathrm{and}{U}_R^2$ <mathematica-file id="MATHEMATICA-00004" file="US20020050567A1-20020502-M00004.NB"/> <image id="EMI-M00004" wi="216.027" he="11.02815" file="US20020050567A1-20020502-M00004.TIF" imf="TIFF" ti="MF"/> </math-cwu> respectively represent the signals delivered by the first and second detector means when the second emitter means is activated.

A method is provided of measuring in vivo of an endogenous fluorophore in a tissue site. A known excitation wavelength of the endogenous flurophore is selected within a range of wavelengths at which the endogenous flurophore undergoes fluorescence. The tissue site is irradiated with irradiated light having at least the selected excitation wavelength within the range of wavelengths. A fluorescence emission of the tissue site resulting from the irradiation thereof is detected. A relative or absolute concentration of the endogenous fluorophore is determined by multiplying it by a calibration factor that depends one at least one of, a known excitation and emission property of the endogenous fluorophore, an intensity of the irradiated light, optical properties of an excitation probe, and specific properties of the tissue. The relative or absolute concentration of the endogenous fluorphore is used to estimate at least one of a, in vivo cellular energy production status or state of end-organ tissue oxygenation.

The invention discloses an infrared cavity ring-down spectroscopy trace gas detection method based on quantum cascade laser; comprising the following steps: using a tunable quantum cascade laser as alight source, and selecting measuring waveband and wavelength scan step length aiming at spectrum line characteristic of the gas to be detected; respectively measuring the cavity ring-down time of each wavelength in the cavity with absorption or without absorption by cavity ring-down technique, and calculating the gas absorption coefficient of corresponding wavelength so as to obtain a relation curve that is an absorption spectrogram of the measured gas absorption coefficient and toned laser wavelength. The spectrogram is contrasted with spectrum line characteristic of corresponding gas in HITRAN database, thereby being capable of analyzing and determining weather the measured gas contains the predetermined gas component; the absolute concentration of the gas to be measured can be calculated and obtained and the absolute concentration of the gas to be measured can be measured through scaling measurement by using absorption peak wavelength of the absorption spectrum as the best detection wavelength and the relation among the gas absorption coefficient of the wavelength, the absorption cross section and concentration. The method has high measuring sensitivity and high property of resisting interference so that the fast and exact on-line analysis and detection of multiple trace gases are easily realized.

A method for measuring the absolute concentration of oxygenated and reduced hemoglobin in human tissue features that its sensor is composed of 2 photoelectric receiving tubes and at least 3 light sources with different wavelengths, which are arranged on a straight line at intervals. Said absolute concentration can be calculated out. Said light source can emit respectively red light and near infrared light.

The invention discloses an antigen antibody complex dissociation liquid kit, which is prepared by blending reagents of 0.3 volume percent of Triton-X100, 1.5 volume percent of lauryl sodium sulfate and 1.5 volume percent of 3-[(3-cholane amidopropyl)-dimethylammonium]propanesulfonic acid in equal amount. The invention also discloses application of the kit in separating a pathogenic antigen antibody complex. The kit of the invention effectively realizes rapid dissociation of the pathogenic antigen antibody complex in a serum or blood plasma sample to be detected, increases the absolute concentration value of an antigen and an antibody, and greatly improves the detection sensitivity of the sample to be detected.

The invention discloses a lipoprotein (a) detection kit which is characterized by consisting of a reagent 1, a reagent 2 and a working calibration solution. The reagent 1 consists of a buffer solution, bull serum albumin (BSA), a surfactant, goat IgG and NaN3; the reagent 2 consists of a buffer solution, a lipoprotein (a) monoclonal antibody latex microsphere, BSA, the surfactant, the goat IgG, a stabilizer and NaN3. The lipoprotein (a) detection kit can be applied to a fully automatic biochemical analyzer, the detection result is high in accuracy, and the lipoprotein (a) has high comparability with absolute concentration of lipoprotein (a) of different crowds and different sizes. Moreover, the lipoprotein (a) detection kit does not have a cross reaction with plasminogen, is not interfered by rheumatoid factors and is high in reagent stability, convenient to use and convenient for large-scale popularization, only a monoclonal antibody of the lipoprotein (a) is needed, and the preparation cost and time of the kit are saved.

In various aspects, the present teachings provide systems, methods, assays and kits for the absolute quantitation of protein expression. In various aspects, the present teachings provide methods of determining the concentration of one or more proteins of interest in one or more samples of interest. In various aspects, the present teachings provide methods of determining the absolute concentration of one or more isoforms of a protein using standard samples of signature protein fragments and parent-daughter ion transition monitoring (PDITM). In various embodiments, the absolute concentration of multiple isoforms of a biomolecule in a sample, multiple proteins in a biological process, a combination of multiple samples, or combinations thereof, can be determined in a multiplex fashion using the present teachings. In various aspects, provided are methods of assessing the response of a biological system to a chemical agent.

The invention relates to application of kelimycin in mycobacterium tuberculosis infection resistance. The application comprises the following main steps: clinical first-line antitubercular drugs isoniazide and rifamycin are used as contrast, and the antimycobacterial activity of kelimycin is detected by adopting an absolute concentration method. The result indicates that the activity of kelimycin on clinically separated mycobacterium tuberculosis including drug-resistance bacteria is remarkably superior to those of the clinical first-line contrast drugs isoniazide and rifamycin, and novel application of kelimycin is expected to be developed in treatment of tubercle bacillus infected diseases.

In various aspects, the present teachings provide systems, methods, assays and kits for the absolute quantitation of protein expression. In various aspects, the present teachings provide methods of determining the concentration of one or more proteins of interest in one or more samples of interest. In various aspects, the present teachings provide methods of determining the absolute concentration of one or more isoforms of a protein using standard samples of signature protein fragments and parent-daughter ion transition monitoring (PDITM). In various embodiments, the absolute concentration of multiple isoforms of a biomolecule in a sample, multiple proteins in a biological process, a combination of multiple samples, or combinations thereof, can be determined in a multiplex fashion using the present teachings. In various aspects, provided are methods of assessing the response of a biological system to a chemical agent.

The invention discloses an automatic device for sample treatment and particle analysis, and a method for sample treatment and particle analysis. A sample pretreatment system in the device comprises a sample pretreatment device, an input device for reaction parameter adjustments, a precise quantitative pipetting and adding device, and a reaction control device; a flow cytometry analysis system in the device can acquire the absolute concentration of a certain kind of targets to be tested. The invention further discloses various work modes in which the device is used for the analysis of the targets to be tested. Through the device and the method disclosed by the invention, the processes of marking reactions, hemolytic reactions and the like can be automatically and precisely controlled, and the parameters such as reaction time and reaction dosage can be adjusted by an operator as needed, so that the experiment consistency and repeatability can be ensured; an absolute concentration analysis of the targets to be tested can be carried out without extra labor or equipment.

The invention discloses a device and a method for measuring the mean concentration of gas in open space. The device comprises a semiconductor laser, a semiconductor laser controller, an optical fiber coupler, an erbium-doped optical fiber amplifier, a photoelectric detector, an optical transceiving antenna, a single-mode optical fiber and a data processing unit. According to the method, a cavity ring-down technology is used to measure the cavity ring-down time of a laser at a wavelength of an absorption spectrum peak of to-be-measured gas and a laser at a wavelength out of the absorption spectrum range respectively, the absorption coefficient of the gas is obtained through calculation, and then the absolute concentration of the gas is solved through calculation according to the relation of the gas absorption coefficient, the absorption section and the concentration; meanwhile, a detection distance calculated through measurement of the time interval of ring-down pulse; the mean concentration of the gas is obtained through calculation on the basis of the known integrated concentration of the gas in the open space and detection distance. The method has the characteristics of high measurement sensitivity and high anti-interference capacity.

A method of determining a measurement value on the basis of a plurality of single molecule events of marker molecules in a sample comprises the steps of selecting the marker molecules from a group of marker molecules which are transferable between a measurable state in which a measurement signal necessary for determining the at least one measurement value is obtainable from the marker molecules and a non-measurable state, of providing the marker molecules in the sample at such an absolute concentration that the at least one measurement value is not determinable, if all marker molecules are in their measurable state, and adjusting a measurement concentration of the marker molecules in the measurable state by means of applying the physical signal to the sample at such an intensity that the at least one measurement value is determinable within a defined measurement area of the sample.

A method for fluorescence detection that provides control of experimental and molecular factors and reliably predicts of concentration from fluorescence intensity measurements utilizing capillary-based flow sensors utilizing a dual detector approach to provide instantaneous normalization of the fluorescent intensity by the Rayleigh scattered intensity measured from the same sensing volume, insensitive to various experimental parameters for prediction of absolute concentrations of fluorescent solutes.

The invention relates to a graphene field effect transistor array biosensor and a preparation method and a detection method thereof. The invention relates to a biosensor and a preparation method and adetection method thereof, aiming at solving the problem of relatively low accuracy in the detection process of the existing graphene field effect transistor array biosensor. The sensor comprises a silicon substrate, an oxidization layer, a first metal grid electrode, a second metal grid electrode, a gate insulating layer, a first graphene conductive channel layer, a second graphene conductive channel layer, a first group source, a leakage electrode, a second group source and a leakage electrode; the preparation method comprises the following steps: I. making a transistor structure; II. performing aldehyde treatment on the graphene surface; III. modifying a detection unit graphene surface to capture antibody molecules; and IV. closing the remaining active sites on the graphene surfaces ofa detection unit and a reference unit; the detection method comprises the following steps: soaking the sensor in a solution containing be-detected antigen, and detecting the voltage at the graphene dirac point of the detection unit and the reference unit, to obtain the absolute concentration of the to-be-detected substance solution, wherein a difference value corresponds to a standard working curve.

The invention provides a method and device for measuring the absolute concentration of singlet-state oxygen (O2(al(delta)). The device comprises a static pool, an infrared detection system and a data acquisition system, wherein the infrared detection system is composed of a chopper, a lens, a narrow-band interference optical filter, an infrared detector and a phase-locked amplifier. In the invention, by monitoring the infrared radiation attenuation change of O2(al(delta)) at 1.27 microns in the static pool and combining the dynamic model analysis in the static pool, the absolute response coefficient of the infrared detection system can be automatically calibrated, and the absolute concentration of O2(al(delta)) can be further measured in real time. Moreover, the infrared attenuation method of the static pool can be applied to the real-time measurement for any flowing system containing O2(al(delta)) by use of a 'flowing-stopping' technology.

Extraction and separation methods that can be used to quantify the absolute concentrations of one or more low abundance biomolecules present in biological fluids and tissues, without the need for antibody enrichment or reliance on an antibody for quantification are provided. These biomolecules can be biomarkers used to diagnose and monitor disease progression. As an example, these methods are applied to human plasma and CSF, and used to quantify Alzheimer's disease biomarkers.

Methods and apparatus are disclosed for determining a substance in a fluid excreted/extracted from the body or spent dialysate, e.g., for determining a quality measure for the dialysis, such as the concentration of selected toxic substances, and/or for determining a removed total quantity of uremic toxins during a dialysis with a dialysis apparatus. A concentration of a substance in the fluid may be determined by: detecting, by an absorption sensor, a first extinction signal of the fluid at an analysis wavelength at a defined first pH value of the fluid; adjusting, by a pH adjusting device, a second pH value of the fluid which differs from the first pH value; detecting, by the absorption sensor, a second extinction signal of the fluid at the analysis wavelength at the second pH value; and processing/comparing the two extinction signals for the first and the second pH values and determining an absolute concentration of the substance dissolved in the fluid.

The present invention provides methods for measuring the absolute concentration of a biomolecule of interest in a subject. Such biomolecules may be implicated in one or more neurological and neurodegenerative diseases or disorders. Also provided is a method for determining whether a therapeutic agent affects the in vivo metabolism of a central nervous system derived biomolecule. Also provided are kits for performing the methods of the invention.